[Application of a seven-day buprenorphine transdermal patch in multimorbid patients on long-term ibuprofen or diclofenac].

Author: BöhmeK, HeckesB, ThomitzekK

Paper Details 
Original Abstract of the Article :
The objective of this study was to evaluate the benefit of a seven-day buprenorphine transdermal patch for patients with chronic musculoskeletal pain previously receiving long-term treatment with ibuprofen or diclofenac alone. Data of a subgroup of 703 patients were analysed which were part of a mul...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/21598463

データ提供:米国国立医学図書館(NLM)

Switching Gears for Pain Relief: Buprenorphine Patches for Multimorbid Patients

The world of pain management is vast and ever-evolving, just like the endless desert sands. This study dives deep into the realm of chronic musculoskeletal pain, a common ailment that can significantly impact an individual's quality of life. The researchers, like seasoned explorers navigating treacherous terrain, sought to evaluate the efficacy of a seven-day buprenorphine transdermal patch for patients who had previously relied on ibuprofen or diclofenac alone. This study employed an observational approach, meticulously analyzing data from a large group of patients with various health conditions, including gastrointestinal, cardiovascular, and renal issues. The study concluded that switching to the buprenorphine patch led to a significant decrease in pain intensity, offering patients a much-needed respite from their suffering. The researchers also highlighted the patch's tolerance and its potential benefit for multimorbid patients, emphasizing that buprenorphine can offer relief without the same cardiac, renal, and gastrointestinal risks associated with other analgesics.

A Patch for Pain, a Patch for Function

The findings revealed a clinically significant decrease in pain intensity, ranging from 5.3 to 2.9 at rest, 7.1 to 3.3 during physical effort, and 4.9 to 1.9 at night. These improvements are not merely numbers on a scale; they translate into a tangible improvement in daily functioning and quality of life. Imagine a patient who could previously barely leave their home due to pain, now able to participate in everyday activities like walking, shopping, or even simply enjoying a meal without discomfort. This newfound freedom and independence, especially for elderly patients, is a significant benefit of the buprenorphine patch.

Beyond Pain Relief: A Holistic Approach

This study sheds light on the complex interplay of pain, physical functioning, and overall well-being. The patch's impact on pain intensity extends far beyond a mere reduction in discomfort. By alleviating pain, the patch allows individuals to regain mobility and engage in activities that contribute to their overall health and happiness. This reinforces the importance of a holistic approach to pain management, considering not just pain itself, but also its impact on daily life and the overall well-being of the patient.

Dr. Camel's Conclusion

This study is a testament to the ever-expanding frontiers of pain management. The seven-day buprenorphine patch offers a promising alternative for patients with chronic musculoskeletal pain, particularly those with multiple health issues. It's like discovering a hidden oasis in the vast desert of pain – a source of relief and the possibility of a more fulfilling life. However, it's crucial to consult with a healthcare professional before making any changes to your pain management regimen. As always, remember to listen to your body, stay hydrated, and keep seeking out knowledge and understanding in the vast desert of medical information!

Date :
  1. Date Completed 2011-06-21
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

21598463

DOI: Digital Object Identifier

21598463

Related Literature

SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.